Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

COPD Exacerbation Modelling Using Unobtrusive Sensors - the TOLIFE Clinical Study A — Stella

Home/Chronic Obstructive Pulmonary Disease (COPD)/COPD Exacerbation Modelling Using Unobtrusive Sensors - the TOLIFE Clinical Study A

View on ClinicalTrials.gov

Recruiting

Back to Chronic Obstructive Pulmonary Disease (COPD) trials

COPD Exacerbation Modelling Using Unobtrusive Sensors - the TOLIFE Clinical Study A

Trial locations(3 sites)

Germany

Pulmonary Research Institute, Großhansdorf, Schleswig-Holstein

Italy

Azienda Ospedaliero Universitaria Pisana, Pisa

Spain

Hospital del Mar Research Institute, Barcelona

Key details

Sponsor

Barcelona Institute for Global Health

Collaborators

University of Pisa, LungenClinic Grosshansdorf

Enrollment target

~150 participants

Started

May 2024

Primary completion

July 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

40 Years and older

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.